CLDX vs NOK · rev $37.0K vs P/E 87, $78.04B cap
Celldex Therapeutics Inc (CLDX) versus Nokia Corp ADR (NOK) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Nokia Corp ADR (NOK) is a communication equipment company listed on NYSE.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
NOK does not have a complete income-statement cache yet.
CLDX currently screens at market cap $2.35B. NOK currently screens at market cap $78.04B and trailing P/E 87.4.
Not investment advice. Open the CLDX and NOK stock pages for the full models.
Not investment advice.